相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A New Old Target: Androgen Receptor Signaling and Advanced Prostate Cancer
Daniel Westaby et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2022)
Human prostate cancer bone metastases have an actionable immunosuppressive microenvironment
Youmna Kfoury et al.
CANCER CELL (2021)
Age and Tumor Differentiation-Associated Gene Expression Based Analysis of Non-Familial Prostate Cancers
Shashwat Sharad et al.
FRONTIERS IN ONCOLOGY (2021)
INPP4B protects from metabolic syndrome and associated disorders
Manqi Zhang et al.
COMMUNICATIONS BIOLOGY (2021)
Inositol polyphosphate 4-phosphatase type II regulation of androgen receptor activity
Manqi Zhang et al.
ONCOGENE (2019)
Emerging therapeutic targets for patients with advanced prostate cancer
Fred Saad et al.
CANCER TREATMENT REVIEWS (2019)
Joint analysis of heterogeneous single-cell RNA-seq dataset collections
Nikolas Barkas et al.
NATURE METHODS (2019)
An aberrant SREBP-dependent lipogenic program promotes metastatic prostate cancer
Ming Chen et al.
NATURE GENETICS (2018)
Clinical implications of PTEN loss in prostate cancer
Tamara Jamaspishvili et al.
NATURE REVIEWS UROLOGY (2018)
A comprehensive evaluation of CHEK2 germline mutations in men with prostate cancer
Yishuo Wu et al.
PROSTATE (2018)
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator
Jung Kim et al.
CELL REPORTS (2018)
A Cellular Anatomy of the Normal Adult Human Prostate and Prostatic Urethra
Gervaise H. Henry et al.
CELL REPORTS (2018)
Epigenetic regulation of cancer progression by EZH2: from biological insights to therapeutic potential
Lu Gan et al.
BIOMARKER RESEARCH (2018)
Enhancer of Zeste homolog 2 (EZH2) induces epithelial-mesenchymal transition in endometriosis
Qi Zhang et al.
SCIENTIFIC REPORTS (2017)
Targeting EZH2 in cancer therapy
Makoto Yamagishi et al.
CURRENT OPINION IN ONCOLOGY (2017)
ASC-J9®, and not Casodex or Enzalutamide, suppresses prostate cancer stem/progenitor cell invasion via altering the EZH2-STAT3 signals
Simeng Wen et al.
CANCER LETTERS (2016)
BRD4 Regulates EZH2 Transcription through Upregulation of C-MYC and Represents a Novel Therapeutic Target in Bladder Cancer
Xinchao Wu et al.
MOLECULAR CANCER THERAPEUTICS (2016)
Inhibition of Notch pathway arrests PTEN-deficient advanced prostate cancer by triggering p27-driven cellular senescence
Ajinkya Revandkar et al.
NATURE COMMUNICATIONS (2016)
The Molecular Taxonomy of Primary Prostate Cancer
Adam Abeshouse et al.
CELL (2015)
INPP4B Is a PtdIns(3,4,5)P3 Phosphatase That Can Act as a Tumor Suppressor
Satoshi Kofuji et al.
CANCER DISCOVERY (2015)
MYC Drives Pten/Trp53-Deficient Proliferation and Metastasis due to IL6 Secretion and AKT Suppression via PHLPP2
Dawid G. Nowak et al.
CANCER DISCOVERY (2015)
CBP Loss Cooperates with PTEN Haploinsufficiency to Drive Prostate Cancer: Implications for Epigenetic Therapy
Liya Ding et al.
CANCER RESEARCH (2014)
INPP4B suppresses prostate cancer cell invasion
Myles C. Hodgson et al.
CELL COMMUNICATION AND SIGNALING (2014)
Pten Null Prostate Epithelium Promotes Localized Myeloid-Derived Suppressor Cell Expansion and Immune Suppression during Tumor Initiation and Progression
Alejandro J. Garcia et al.
MOLECULAR AND CELLULAR BIOLOGY (2014)
The Histone H3 Lysine 9 Methyltransferases G9a and GLP Regulate Polycomb Repressive Complex 2-Mediated Gene Silencing
Chiara Mozzetta et al.
MOLECULAR CELL (2014)
Copy number alteration burden predicts prostate cancer relapse
Haley Hieronymus et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Hexokinase 2-Mediated Warburg Effect Is Required for PTEN- and p53-Deficiency-Driven Prostate Cancer Growth
Lei Wang et al.
CELL REPORTS (2014)
Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
Jianjiong Gao et al.
SCIENCE SIGNALING (2013)
The role of BRCA1 and BRCA2 in prostate cancer
Elena Castro et al.
ASIAN JOURNAL OF ANDROLOGY (2012)
AKT induces senescence in human cells via mTORC1 and p53 in the absence of DNA damage: implications for targeting mTOR during malignancy
M. V. Astle et al.
ONCOGENE (2012)
EZH2 Oncogenic Activity in Castration-Resistant Prostate Cancer Cells Is Polycomb-Independent
Kexin Xu et al.
SCIENCE (2012)
The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
Ethan Cerami et al.
CANCER DISCOVERY (2012)
Prostate Epithelial Pten/TP53 Loss Leads to Transformation of Multipotential Progenitors and Epithelial to Mesenchymal Transition
Philip Martin et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Cell Autonomous Role of PTEN in Regulating Castration-Resistant Prostate Cancer Growth
David J. Mulholland et al.
CANCER CELL (2011)
Reciprocal Feedback Regulation of PI3K and Androgen Receptor Signaling in PTEN-Deficient Prostate Cancer
Brett S. Carver et al.
CANCER CELL (2011)
Decreased Expression and Androgen Regulation of the Tumor Suppressor Gene INPP4B in Prostate Cancer
Myles C. Hodgson et al.
CANCER RESEARCH (2011)
Inositol Polyphosphate 4-Phosphatase B as a Regulator of Bone Mass in Mice and Humans
Mathieu Ferron et al.
CELL METABOLISM (2011)
SMAD4-dependent barrier constrains prostate cancer growth and metastatic progression
Zhihu Ding et al.
NATURE (2011)
Integrative Genomic Profiling of Human Prostate Cancer
Barry S. Taylor et al.
CANCER CELL (2010)
The retinoblastoma tumor suppressor controls androgen signaling and human prostate cancer progression
Ankur Sharma et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Protein pathway biomarker analysis of human cancer reveals requirement for upfront cellular-enrichment processing
Alessandra Silvestri et al.
LABORATORY INVESTIGATION (2010)
ETS Transcription Factors Control Transcription of EZH2 and Epigenetic Silencing of the Tumor Suppressor Gene Nkx3.1 in Prostate Cancer
Paolo Kunderfranco et al.
PLOS ONE (2010)
Slug/SNAI2 regulates cell proliferation and invasiveness of metastatic prostate cancer cell lines
Modjtaba Emadi Baygi et al.
TUMOR BIOLOGY (2010)
Evidence that Inositol Polyphosphate 4-Phosphatase Type II Is a Tumor Suppressor that Inhibits PI3K Signaling
Christina Gewinner et al.
CANCER CELL (2009)
Pathway Biomarker Profiling of Localized and Metastatic Human Prostate Cancer Reveal Metastatic and Prognostic Signatures
Robert L. Grubb et al.
JOURNAL OF PROTEOME RESEARCH (2009)
Insulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40
Emilie Vander Haar et al.
NATURE CELL BIOLOGY (2007)
Akt-mediated phsophorylationof EZH2 suppresses methylation of lysine 27 in histone H3
TL Cha et al.
SCIENCE (2005)
Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis
ZB Chen et al.
NATURE (2005)
SLUG in cancer development
PA Pérez-Mancera et al.
ONCOGENE (2005)
Molecular determinants of resistance to antiandrogen therapy
CD Chen et al.
NATURE MEDICINE (2004)
EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer
AP Bracken et al.
EMBO JOURNAL (2003)
Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer
SY Wang et al.
CANCER CELL (2003)
Role of histone H3 lysine 27 methylation in polycomb-group silencing
R Cao et al.
SCIENCE (2002)
The polycomb group protein EZH2 is involved in progression of prostate cancer
S Varambally et al.
NATURE (2002)
分享论文
